痴呆和听力损失:从风险到机制和管理
Emma E Broome1,2, Sian Calvert1,2, Eithne Heffernan3
1National Institute for Health and Care Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Frontiers in dementia
|March 5, 2026
概括
中年听力损失是痴呆症的一个关键风险因素. 解决听力障碍可能有助于预防认知衰退和痴呆症,强调综合护理和多样化的研究.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 老年学是一门学科.
背景情况:
- 中年听力损失是痴呆症的一个显著的,可修改的风险因素.
- 连接听力损失和痴呆症的确切机制尚不清楚,阻碍了干预措施的发展.
研究的目的:
- 审查有关与听力损失相关的痴呆风险的现有证据.
- 探索建议的机制和听力干预措施的有效性.
- 突出综合护理和多样化的研究群体的需要.
主要方法:
- 关于听力损失和痴呆症现有研究的文献综述.
- 对拟议的生物和社会机制进行分析.
- 对用于认知健康的听力干预措施研究的评估.
主要成果:
- 听力损失与痴呆症风险增加密切相关.
- 提出了几种合理的机制,包括认知负载和社会隔离.
- 新出现的证据表明,听力干预可能会对认知轨迹产生积极影响.
结论:
- 听力损失是一个关键的,可修改的痴呆症风险因素.
- 针对听力损失的干预措施显示出对痴呆症预防和管理的希望.
- 综合护理和包容性研究对于推进痴呆症平等至关重要.
相关概念视频
Dementia
632
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
632
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Atherosclerosis III: Management
532
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
532
Hypertension V: Nursing Management
571
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
571
Hearing
58.1K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
58.1K


